Fennec Pharmaceuticals (FENC) Net Cash Flow Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 64.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.88% |
| Sep 30, 2025 | -39.77% |
| Jun 30, 2025 | -5.89% |
| Mar 31, 2025 | -11.70% |
| Dec 31, 2024 | -61.73% |
| Sep 30, 2024 | 2.59% |
| Jun 30, 2024 | -22.47% |
| Mar 31, 2024 | 132.40% |
| Dec 31, 2023 | 32.16% |
| Sep 30, 2023 | 22.81% |
| Jun 30, 2023 | -28.44% |
| Mar 31, 2023 | -12.82% |
| Dec 31, 2022 | -55.50% |
| Sep 30, 2022 | 105.19% |
| Jun 30, 2022 | -6.66% |
| Mar 31, 2022 | -3.67% |
| Dec 31, 2021 | -22.89% |
| Sep 30, 2021 | -38.39% |
| Jun 30, 2021 | -60.08% |
| Mar 31, 2021 | -32.60% |
| Dec 31, 2020 | -29.11% |
| Sep 30, 2020 | -117.06% |
| Jun 30, 2020 | 60.43% |
| Mar 31, 2020 | -77.09% |
| Dec 31, 2019 | -37.55% |
| Sep 30, 2019 | -60.16% |
| Jun 30, 2019 | -37.64% |
| Mar 31, 2019 | -85.89% |
| Dec 31, 2018 | -60.19% |
| Sep 30, 2018 | -31.75% |
| Jun 30, 2018 | -159.15% |
| Mar 31, 2018 | -57.96% |
| Dec 31, 2017 | 121.28% |
| Sep 30, 2017 | -8.83% |
| Jun 30, 2017 | 186.89% |
| Mar 31, 2017 | -27.59% |
| Dec 31, 2016 | -36.50% |
| Sep 30, 2016 | -5.07% |
| Jun 30, 2016 | 92.22% |
| Mar 31, 2016 | 0.83% |
| Dec 31, 2015 | 8.69% |
| Sep 30, 2015 | 12.40% |
| Jun 30, 2015 | 62.03% |
| Mar 31, 2015 | 12.22% |
| Dec 31, 2014 | 61.79% |
| Sep 30, 2014 | 12.78% |
| Jun 30, 2014 | -29.71% |
| Mar 31, 2014 | 32.31% |
| Dec 31, 2013 | 54.91% |
| Sep 30, 2013 | 5.17% |
| Jun 30, 2013 | -28.68% |